Ignite Creation Date:
2024-05-05 @ 11:46 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00128375
Status:
COMPLETED
Last Update Posted:
2007-12-17
First Post:
2005-08-08
Brief Title:
Financial Incentives for Smoking Cessation
Sponsor:
University of Pennsylvania
Organization:
University of Pennsylvania
Study Overview
Official Title:
Financial Incentives for Smoking Cessation
Status:
COMPLETED
Status Verified Date:
2007-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to test the effectiveness of financial incentives for increasing long-term smoking cessation rates among employees at General Electric worksites throughout the United States
Detailed Description:
Smoking is the leading cause of preventable mortality in United States accounting for approximately 435000 of the 24 million deaths each year in the United States Most smokers make multiple attempts to quit smoking but only 2-3 succeed each year Smoking cessation programs have proven effective in helping smokers quit but only about 5 of smokers enroll in smoking cessation programs each year
Financial incentives have been shown to increase enrollment in smoking cessation programs and short-term quit rates but have not been well tested as a mechanism for increasing long-term quit rates The existing evidence suggests that they could be highly effective particularly among heavy smokers and low income smokers In addition financial incentives for smoking cessation will likely be more cost effective than most covered health services and at least as cost effective as other recommended smoking cessation treatments
This study is a two-arm randomized clinical trial of financial incentives for smoking cessation among a sample of 850 male and female smokers from GE Energy worksites throughout the US Smokers will be randomized to receive either usual care information about local community-based smoking cessation resources coverage of prescription drugs and physician visits or usual care plus a package of financial incentives that includes 100 for completion of a community-based tobacco cessation program 250 for short-term smoking cessation at either 3 months or 6 months after randomization and 400 for smoking cessation 6 months post-quit date biochemically confirmed
Financial incentives have been shown to increase enrollment in smoking cessation programs and short-term quit rates but have not been well tested as a mechanism for increasing long-term quit rates The existing evidence suggests that they could be highly effective particularly among heavy smokers and low income smokers In addition financial incentives for smoking cessation will likely be more cost effective than most covered health services and at least as cost effective as other recommended smoking cessation treatments
This study is a two-arm randomized clinical trial of financial incentives for smoking cessation among a sample of 850 male and female smokers from GE Energy worksites throughout the US Smokers will be randomized to receive either usual care information about local community-based smoking cessation resources coverage of prescription drugs and physician visits or usual care plus a package of financial incentives that includes 100 for completion of a community-based tobacco cessation program 250 for short-term smoking cessation at either 3 months or 6 months after randomization and 400 for smoking cessation 6 months post-quit date biochemically confirmed
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 1R01DP000100-03 | NIH | None | httpsreporternihgovquickSearch1R01DP000100-03 |